Related Experiment Video
Updated: Jul 5, 2026

Evaluating the Effectiveness of Cancer Drug Sensitization In Vitro and In Vivo
Published on: February 6, 2015
[Limitations and pitfalls of clinical studies in oncology]
1Fachbereich Onkologie/Hämatologie, Departement Innere Medizin, Kantonsspital St. Gallen, Schweiz. thomas.cerny@kssg.ch
Abstract:
Nowadays results of clinical studies in oncology are often first found and commented in the news media because of their high relevance to the pharmaceutical market. The limits and pitfalls of clinical studies are manifold and not always appreciated even by specialists as well as journalists and politicians. The planning of a study is a most crucial phase, and most deficits are due to inappropriate design and conduct of a study. Adequate and skilful interpretation of a study is often hampered by many known but mostly overlooked variable pitfalls. Today there is an overrepresentation of pharmaceutically sponsored studies and a painful lack of well-designed academic studies with really meaningful endpoints for patient care. This paper touches several important aspects of today's shortcomings of clinical studies in oncology and highlights the importance of strengthening the academic clinical research. Evidence-based medicine needs to be more clinically relevant, and therefore we need well-designed, and critically interpreted studies in the future.
Insights
Clinical oncology studies require careful planning and interpretation to ensure patient relevance. Strengthening academic research is crucial for evidence-based medicine and meaningful clinical endpoints.
Area of Science:
- Oncology
- Clinical Research
- Evidence-Based Medicine
Context:
- Clinical oncology study results are frequently disseminated and interpreted by media due to market relevance.
- Limitations and potential pitfalls in clinical studies are often underestimated by specialists, journalists, and politicians.
- There is a notable overrepresentation of pharmaceutical-sponsored studies, contrasting with a deficit in well-designed academic research focused on patient care.
Purpose:
- To identify and discuss current shortcomings in clinical oncology studies.
- To emphasize the critical importance of robust academic clinical research.
- To advocate for improved study design and interpretation for greater clinical relevance.
Summary:
- Deficits in clinical studies often stem from inappropriate design and conduct during the planning phase.
- Accurate interpretation of study findings is frequently hindered by overlooked variables and pitfalls.
- The paper highlights the need for clinically relevant endpoints in oncology research.
Impact:
- Enhancing academic clinical research is vital for advancing evidence-based medicine.
- Future oncology research must prioritize well-designed studies with critical interpretation.
- This work aims to improve the clinical relevance and reliability of oncology study outcomes.
Related Concept Videos
Clinical Trials
There are four phases in a clinical trial. A phase one...
Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast, controlled...
Clinical Trials: Overview
Mouse Models of Cancer Study
The development of transgenic, knockout, and knock-in mice has led to an exponential increase in their use as model organisms in research,...
Longitudinal Research
Cancer Therapies
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...